RESUMO
In the world the most frequent and cosmopolitan parasitosis of all human helminthiasis is that caused by ascaris lumbricoides this sickness affects 1.5 billion people around the world, and approximately 60,000 people die annually as the result, about of complications, the intestinal obstruction being the most frequent complication from 38 to 87.5%, the humans become infected by ingesting the larvated eggs of the parasite. OPS report a prevalence of 46 million children between 1-year-old and 14 years old, the most importance prevalence occurs in children between 2 years old and 10 years old, decreasing significantly from the 15 years old. Mexico report through SINAVE (SEMARNAT 2020) a national incidence of 24,203 cases, the State of Sinaloa a total of 690 cases (2.8%). Lack of sanitation, drinking water and precariousness are risk factors for complications such as obstruction a complication that can progress to death.
RESUMO
A 23-year-old female with a history of long-standing obesity, recently was diagnosed with cholelithiasis, along with a 15 day development of jaundice. An ERCP (endoscopic retrograde cholangiopancreatography) was performed, during which resulted an unsuccessful sphincterotomy, this was followed by placing a 7-centimeter, 10 French Amsterdam-type stent, subsequently she experienced sudden abdominal pain, and a CT scan revealed a subcapsular hepatic hematoma, which required surgical management. The objective was to describe a clinical case of subcapsular hepatic hematoma, clinical presentation, and therapeutic conduct. The treatment of subcapsular hepatic hematoma will depend on the patient's hemodynamic stability. However, survival is uncertain due to its rarity, making it crucial to recognize its early signs and symptoms and act promptly.
RESUMO
O desempenho, o peso de alguns órgãos e a morfologia vulvar de leitoas pré-púberes, alimentadas por 28 dias com dietas contendo zearalenona, foram avaliados. O delineamento experimental utilizado foi inteiramente ao acaso, com dois tratamentos, dieta controle (DC) e dieta controle + 2mg kg-1 de zearalenona (DZ), e seis repetições cada. Não houve diferença (P>0,05) entre os tratamentos para consumo médio diário de ração (1,24 x 1,19kg), ganho médio diário de peso (0,68 x 0,71kg), conversão alimentar (1,86 x 1,71) e peso vivo (PV); (30,9 x 30,4kg). A zearalenona não alterou (P>0,05) os pesos absoluto e relativo do coração (137 x 141g e 0,45 x 0,45 por cento PV), fígado (699 x 699g e 2,31 x 2,26 por centoPV), rins (47 x 49g e 0,15 x 0,16 por centoPV) e baço (166 x 171g e 0,55 x 0,55 por centoPV). Houve aumento (P<0,05) no comprimento (17 x 27cm) e no peso (23 x 157g e 0,07 x 0,51 por centoPV) do trato reprodutivo das leitoas do grupo DZ. O volume vulvar ao final do período foi 820 por cento maior (P<0,05) nos animais alimentados com zearalenona (941 x 8658mm³/kgPV0,6). Os resultados indicam que em suínos a zearalenona e seus metabólitos possuem atividade estrogênica, mas não interferem no desempenho dos animais.
The performance, the weights of some organs, and the vulvae morphology in pre-pubertal gilts fed diets containing zearalenone were evaluated during 28 days. The experimental design was completely randomized with two treatments (control diet, ZD - control diet + 2mg kg-1 of zearalenone) and six replications of each were done. No differences (P>0.05) between treatments for daily feed intake (1.24 x 1.19kg), average daily gain (0.68 x 0.71kg), feed conversion ratio (1.86 x 1.71), and live weight (30.9 x 30.4kg) were observed. Zearalenone did not change (P>0.05) the absolute and relative weights of heart (137 x 141g and 0.45 x 0.45 percentBW), liver (699 x 699g and 2.31 x 2.26 percentBW), kidneys (47 x 49g and 0.15 x 0.16 percentBW), and spleen (166 x 171g and 0.55 x 0.55 percent BW). However, zearalenone increased (P<0.05) the length (17 x 27cm) and weight (23 x 157g and 0.07 x 0.51 percentBW) of the reproductive tract. The final vulvae volume was 820 percent larger (P<0.05) in gilts fed diets containing zearalenone than those fed control diet (941 x 8658mm³/kgBW0.6). Results suggested that zearalenone and its metabolites have an estrogenic activity in pigs without changing the animal performance.